Novo Nordisk has announced today that the US Food and Drug Administration (FDA) has granted approval for an expanded label for Wegovy®. This approval, based on a supplemental New Drug…
Eli Lilly and Company (NYSE: LLY) has disclosed findings from a pioneering investigation into lebrikizumab, tailored specifically for individuals with skin of color grappling with moderate-to-severe atopic dermatitis, commonly known…
Eli Lilly and Company (NYSE: LLY) has announced that the U.S. Food and Drug Administration (FDA) plans to convene a meeting of the Peripheral and Central Nervous System Drugs Advisory…
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading biopharmaceutical firm specializing in the discovery, acquisition, development, and distribution of innovative therapies for rare and orphan diseases, has revealed its participation in…
Oragenics, Inc. (NYSE American: OGEN), a company dedicated to developing innovative intranasal pharmaceuticals for neurological disorders, has revealed its readiness to embark on the final stages of GMP manufacturing and…
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on seralutinib for pulmonary arterial hypertension (PAH) treatment, reported its financials for Q4 and full-year 2023 and updated on business…
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a pioneer in RNAi therapeutics, has announced positive results from the KARDIA-2 Phase 2 study of zilebesiran, an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT)…
Argonaut Manufacturing Services Secures $45M Funding for Expanded Pharma Fill / Finish Facility Argonaut Manufacturing Services, a prominent contract development and manufacturing organization in the biopharma and life sciences sectors,…
Aktana Unveils “Aktana for MedTech” to Revolutionize HCP Engagement Aktana, the forefront in intelligent customer engagement for global life sciences and the medical sector, has introduced “Aktana for MedTech.” This…
Summit Therapeutics (NASDAQ: SMMT) will present at the Barclays 26th Global Healthcare Conference in Miami Beach, FL from March 12-14, 2024. CEO Dr. Maky Zanganeh and Chairman Robert W. Duggan…
ResearchAndMarkets.com is pleased to announce the addition of the “FARXIGA Market Size, Forecast, and Emerging Insight – 2032” report to its offerings. This comprehensive report delves into the impact and…
Merck (NYSE: MRK), also known as MSD outside the United States and Canada, has revealed that Jannie Oosthuizen, President of Human Health U.S., is set to engage in a fireside…